Uber die Synthese von XeF6

Claassen und Mitarb.1 berlichten iiber die Syinthese von XeF4 , R. Hoppe und Mifarb.2 iiber die Synthese von XeF2 • Wir haiben die Synthese VO!!l XeF43 reproduzii.ert und koomten bei der massenspektrometrischen Analyse des Produktes schwache Andeutungen fiir die .Ainwesenheit hoherer Fluoride feststellen

Is diet partly responsible for differences in COVID-19 death rates between and within countries?

Correction: Volume: 10 Issue: 1 Article Number: 44 DOI: 10.1186/s13601-020-00351-w Published: OCT 26 2020Reported COVID-19 deaths in Germany are relatively low as compared to many European countries. Among the several explanations proposed, an early and large testing of the population was put forward. Most current debates on COVID-19 focus on the differences among countries, but little attention has been given to regional differences and diet. The low-death rate European countries (e.g. Austria, Baltic States, Czech Republic, Finland, Norway, Poland, Slovakia) have used different quarantine and/or confinement times and methods and none have performed as many early tests as Germany. Among other factors that may be significant are the dietary habits. It seems that some foods largely used in these countries may reduce angiotensin-converting enzyme activity or are anti-oxidants. Among the many possible areas of research, it might be important to understand diet and angiotensin-converting enzyme-2 (ACE2) levels in populations with different COVID-19 death rates since dietary interventions may be of great benefit.Peer reviewe

GMO sampling strategies in food and feed chains

The sampling step is relevant whenever it is necessary to evaluate an analyte in a lot. However, sampling is by far the most crucial step when the analyte is heterogeneously distributed in the lot, especially at low concentration, because high sampling uncertainty could invalidate the overall analytical testing. The economic and legal implications of such failure could greatly exceed the very high cost of accurate sampling. When there is a legal requirement that the analyte be analytically traced, low sampling reliability at any step of the production and distribution chains could cause the entire traceability system to fail. These considerations also apply to the legally - imposed GMO requirements, particularly those for labelling and traceability. Improper sampling can mislead both food producers and consumers about the GM content in products. In addition, if GMO tests fail to detect an unauthorised GM crop, those unauthorised crops could pose potential risks to human and animal health. Failure of traceability could result in collapse of transgenic and conventional/organic co - existence in the fi eld, with subsequent environmental and economic consequences. A sampling plan should be reliable, cost - effective and feasible in the real life. ‘ Fit - for - purpose ’ sampling plans should be studied and applied, given the wide variety of field situations and ultimate goals. In addition, the uncertainty level of the ‘ overall analytical chain ’ is relevant in many respects, such as making decisions about the best procedures to put in place. Uncertainty in GMO sampling is high, therefore statistical studies should be performed to evaluate sampling uncertainty or at least generate insight into how to make responsible decisions on the most appropriate sampling plan to adopt at each step of the food and feed chain. Prior to the European research project Co - Extra, valuable and indispensible research had been conducted on topics such as the distribution of GMOs in a lot and the implementation of reliable software tools to reveal the most suitable sample size for GMO detection. Research conducted within the Co - Extra project fi lled in relevant theoretical gaps related to the assessment of control plans. All of this research represents a basis for selecting appropriate sampling plans that are best adapted to the operational conditions.JRC.I.3-Molecular Biology and Genomic

Correction to: Is diet partly responsible for differences in COVID-19 death rates between and within countries? (Clinical and Translational Allergy, (2020), 10, 1, (16), 10.1186/s13601-020-00323-0)

Following publication of the original article [1], the authors identified an error in the affiliation list. The affiliation of author G. Walter Canonica should have been split up into two affiliations: • Personalized Medicine, Asthma and Allergy – Humanitas Clinical and Research Center – IRCCS, Rozzano (MI), Italy • Department of Biomedical Sciences, Humanitas University, Pieve Emanuele (MI), Italy The corrected affiliation list is reflected in this Correction. © 2020, The Author(s)